|
| 37984511 | Vagus nerve dysfunction in the post-COVID-19 condition: a pilot cross-sectional study. | Clin Microbiol Infect | 2024 |
| 36354046 | Immunological and virological findings in a patient with exceptional post-treatment control: a case report. | Lancet HIV | 2023 |
| 37954002 | Determinants of the onset and prognosis of the post-COVID-19 condition: a 2-year prospective observational cohort study. | Lancet Reg Health Eur | 2023 |
| 37749751 | HIV drug resistance in the era of contemporary antiretroviral therapy: A clinical perspective. | Antivir Ther | 2023 |
| 38005995 | Vaccination with an HIV T-Cell Immunogen (HTI) Using DNA Primes Followed by a ChAdOx1-MVA Boost Is Immunogenic in Gut Microbiota-Depleted Mice despite Low IL-22 Serum Levels. | Vaccines (Basel) | 2023 |
| 37738247 | Recommendations on data sharing in HIV drug resistance research. | PLoS Med | 2023 |
| 37978296 | "The burden of post-acute COVID-19 symptoms in a multinational network cohort analysis". | Nat Commun | 2023 |
| 37537214 | Genetic risk, adherence to healthy lifestyle and acute cardiovascular and thromboembolic complications following SARS-COV-2 infection. | Nat Commun | 2023 |
| 37213438 | Long-Term Benefits from Early Antiretroviral Therapy Initiation in HIV Infection. | NEJM Evid | 2023 |
| 37142994 | Time from symptoms onset to remdesivir is associated with the risk of ICU admission: a multicentric analyses. | BMC Infect Dis | 2023 |
| 37074613 | Consistent Effects of Early Remdesivir on Symptoms and Disease Progression Across At-Risk Outpatient Subgroups: Treatment Effect Heterogeneity in PINETREE Study. | Infect Dis Ther | 2023 |
| 37363245 | Methicillin-resistant and methicillin-sensitive <i>Staphylococcus aureus</i> in pork industry workers, Catalonia, Spain. | One Health | 2023 |
| 37395474 | Impact of Obefazimod on Viral Persistence, Inflammation, and Immune Activation in People With Human Immunodeficiency Virus on Suppressive Antiretroviral Therapy. | J Infect Dis | 2023 |
| 36751730 | Impact of Antibiotic Treatment on the Gut Microbiome and its Resistome in Hematopoietic Stem Cell Transplant Recipients. | J Infect Dis | 2023 |
| 36642087 | Predicted effects of the introduction of long-acting injectable cabotegravir pre-exposure prophylaxis in sub-Saharan Africa: a modelling study. | Lancet HIV | 2023 |
| 36909731 | Plitidepsin in adult patients with COVID-19 requiring hospital admission: A long-term follow-up analysis. | Front Cell Infect Microbiol | 2023 |
| 36370091 | Evaluating the Accuracy of Self-Collected Swabs for the Diagnosis of Mpox. | Clin Infect Dis | 2023 |
| 34923600 | Gut microbiome in hemodialysis patients treated with calcium acetate or treated with sucroferric oxyhydroxide: a pilot study. | Int Urol Nephrol | 2022 |
| 35548869 | The gut microbiome in patients with chronic lymphocytic leukemia. | Haematologica | 2022 |
| 35410461 | Gut microbiome signatures linked to HIV-1 reservoir size and viremia control. | Microbiome | 2022 |
| 35580040 | Evaluating Primary Endpoints for COVID-19 Therapeutic Trials to Assess Recovery. | Am J Respir Crit Care Med | 2022 |
| 35501220 | New Antivirals and Immune Therapies for COVID-19 Infection. | Arch Bronconeumol | 2022 |
| 35762509 | Lamivudine, a reverse transcriptase inhibitor, rescues cognitive deficits in a mouse model of down syndrome. | J Cell Mol Med | 2022 |
| 35495657 | Trends of Transmitted and Acquired Drug Resistance in Europe From 1981 to 2019: A Comparison Between the Populations of Late Presenters and Non-late Presenters. | Front Microbiol | 2022 |
| 35821254 | Author Correction to: SARS-CoV-2 interaction with Siglec-1 mediates trans-infection by dendritic cells. | Cell Mol Immunol | 2022 |
| 35631460 | Safety of Short-Term Treatments with Oral Chloroquine and Hydroxychloroquine in Patients with and without COVID-19: A Systematic Review. | Pharmaceuticals (Basel) | 2022 |
| 35425985 | Removal of doravirine by haemodialysis in people living with HIV with end-stage renal disease. | J Antimicrob Chemother | 2022 |
| 35688854 | Remdesivir for the treatment of patients hospitalized with COVID-19 receiving supplemental oxygen: a targeted literature review and meta-analysis. | Sci Rep | 2022 |
| 35620108 | Performance of SARS-CoV-2 Antigen-Detecting Rapid Diagnostic Tests for Omicron and Other Variants of Concern. | Front Microbiol | 2022 |
| 35619701 | Skewed Cellular Distribution and Low Activation of Functional T-Cell Responses in SARS-CoV-2 Non-Seroconvertors. | Front Immunol | 2022 |
| 36552852 | Pre-Transplant Prediction of Acute Graft-versus-Host Disease Using the Gut Microbiome. | Cells | 2022 |
| 36619546 | Factors associated with critical care requirements in diabetic patients treated with dexamethasone for COVID-19 infection in the first wave of the pandemia. | Front Endocrinol (Lausanne) | 2022 |
| 36585401 | Vaccination with an HIV T-cell immunogen induces alterations in the mouse gut microbiota. | NPJ Biofilms Microbiomes | 2022 |
| 36569851 | Probiotic effects on immunity and microbiome in HIV-1 discordant patients. | Front Immunol | 2022 |
| 35939810 | Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19 : A Randomized Controlled Trial. | Ann Intern Med | 2022 |
| 36101771 | A simple new screening tool for diagnosing imported schistosomiasis. | Public Health Pract (Oxf) | 2022 |
| 36037469 | The Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19. | Ann Intern Med | 2022 |
| 35866437 | Integrated use of laboratory services for multiple infectious diseases in the WHO European Region during the COVID-19 pandemic and beyond. | Euro Surveill | 2022 |
| 36232416 | Metabolic Potential of the Gut Microbiome Is Significantly Impacted by Conditioning Regimen in Allogeneic Hematopoietic Stem Cell Transplantation Recipients. | Int J Mol Sci | 2022 |
| 36200261 | Limited Humoral and Specific T-Cell Responses After SARS-CoV-2 Vaccination in PWH With Poor Immune Reconstitution. | J Infect Dis | 2022 |
| 35952705 | Clinical presentation and virological assessment of confirmed human monkeypox virus cases in Spain: a prospective observational cohort study. | Lancet | 2022 |
| 35980616 | Clinical and Genetic Risk Factors for Acute Incident Venous Thromboembolism in Ambulatory Patients With COVID-19. | JAMA Intern Med | 2022 |
| 35948240 | Virological efficacy of switch to DTG plus 3TC in a retrospective observational cohort of suppressed HIV-1 patients with or without past M184V: the LAMRES study. | J Glob Antimicrob Resist | 2022 |
| 36375130 | 2022 update of the drug resistance mutations in HIV-1. | Top Antivir Med | 2022 |
| 35012962 | Preclinical and randomized phase I studies of plitidepsin in adults hospitalized with COVID-19. | Life Sci Alliance | 2022 |
| 35274144 | Integrase resistance emergence with dolutegravir/lamivudine with prior HIV-1 suppression. | J Antimicrob Chemother | 2022 |
| 34969255 | A Summary of the Sixth International Workshop on Microbiome in HIV Pathogenesis, Prevention, and Treatment. | AIDS Res Hum Retroviruses | 2022 |
| 35325780 | Epigenetic landscape in the kick-and-kill therapeutic vaccine BCN02 clinical trial is associated with antiretroviral treatment interruption (ATI) outcome. | EBioMedicine | 2022 |
| 35233547 | Clinical course impacts early kinetics,magnitude, and amplitude of SARS-CoV-2 neutralizing antibodies beyond 1 year after infection. | Cell Rep Med | 2022 |
| 35231500 | Unraveling the antiviral activity of plitidepsin against SARS-CoV-2 by subcellular and morphological analysis. | Antiviral Res | 2022 |